Analytical Validation for qPCR
SEP 29, 2022 | 10:00 AM
Brunie B. White, Ph.D
Field Applications Scientist, Thermo Fisher Scientific
Real-time PCR, also known as quantitative PCR (qPCR), is the gold-standard for sensitive, specific detection and quantification of nucleic acid targets. This technology allows for powerful assay design algorithms, optimized master mixes, intuitive data analysis software, and diverse applications. The Analytical Validation of qPCR assays can, however, be a complex and time-consuming task.
In this webinar we will explore the need for the Analytical Validation (AV) and dive into what it takes to complete a qPCR AV. An experienced Field Applications Scientist, Brunie White, will share her insight into the AV journey focusing on the most accepted validation guidelines, challenges and solutions for a successful Analytical Validation.
Learning objectives:
• Outline the principal validation guidelines
• Discuss the challenges that come with an Analytical Validation
• Discover Thermo Fisher Scientific’s approach to consulting on an AV project
Pharmacogenomics: Post COVID-19 Expansion of Molecular Testing
SEP 29, 2022 | 11:00 AM
Michael J. Donovan, Ph.D., JD
Lecturer, Biomedical Diagnostics, Arizona State University
Mara G. Aspinall
Managing Director, Health Catalysts Group and Professor of Practice, Biomedical Diagnostics, Arizona State University
Marilyn Owens, Ph.D., M.B.A.
Founder and Principal, Medical Laboratory Strategy and Leadership, LLC
Due to the rapid emergence of the SARS-CoV-2 virus, molecular diagnostic technologies have expanded significantly. Although several diagnostic approaches were developed, real-time reverse transcriptase polymerase chain reaction (RT-PCR)-based assays became the primary method for the diagnosis of SARS-CoV-2 infection. Historically used culture-based methods for diagnosing COVID-19 would be insufficient due to long processing times. The sensitivity and specificity of molecular techniques created an immense opportunity for new product development and deployment to serve an urgent and evolving need for testing at large scale. This new opportunity for new testing opens the doors for laboratories to utilize RT-PCR testing for not only COVID-19, but for other infectious diseases as well as genetic testing, such as pharmacogenomics.
This webinar will discuss how to assess your current lab capabilities including technology assessment and understanding your laboratory’s strengths and weaknesses. The speakers will dive into the current market state of molecular testing with a key focus on pharmacogenomics as well as potential opportunities. Finally, the speakers will discuss what it looks like to create an implementation plan that is relevant to your labs needs.